Coffee polyphenols modulate whole-body substrate oxidation and suppress postprandial hyperglycaemia, hyperinsulinaemia and hyperlipidaemia

British Journal of Nutrition

Volumn 107, Issue 12, 2012, Pages 1757-1765

  Murase, Takatoshi ^a   Yokoi, Yuka ^a   Misawa, Koichi ^a   Ominami, Hideo ^a   Suzuki, Yasuto ^a   Shibuya, Yusuke ^a   Hase, Tadashi ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Chlorogenic acid; Energy metabolism; Glucosidase; Hyperglycaemia; Polyphenols

Indexed keywords

3,5 DICAFFEOYL QUINIC ACID; 5 CAFFEOYL QUINIC ACID; 5 FERULOYL QUINIC ACID; ALPHA GLUCOSIDASE; CAFFEIC ACID; FERULIC ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; POLYPHENOL; QUINIC ACID; STARCH; SUCRASE; SUCROSE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CALORIMETRY; CARBOHYDRATE METABOLISM; COFFEE; CONTROLLED STUDY; ENERGY EXPENDITURE; ENERGY METABOLISM; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID METABOLISM; MALE; MOUSE; NONHUMAN; OXIDATION; OXYGEN CONSUMPTION; RESPIRATORY QUOTIENT; WHOLE BODY SUBSTRATE OXIDATION;

ANIMALS; BLOOD GLUCOSE; CELL RESPIRATION; COFFEA; COFFEE; DIETARY CARBOHYDRATES; DIETARY FATS; DIGESTION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENERGY METABOLISM; HYPERGLYCEMIA; HYPERINSULINISM; HYPERLIPIDEMIAS; INSULIN; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; OBESITY; OXIDATION-REDUCTION; OXYGEN CONSUMPTION; PHYTOTHERAPY; PLANT EXTRACTS; POLYPHENOLS; POSTPRANDIAL PERIOD; QUINIC ACID; TRIGLYCERIDES;

EID: 84862546532     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511005083     Document Type: Article

References (37)

1. Després JP, Lemieux I, Bergeron J, et al. (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28, 1039-1049.
2. Kanter JE, Johansson F, LeBoeuf RC, et al. (2007) Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques? Circ Res 100, 769-781. (Pubitemid 46555682)
3. O'Keefe JH & Bell DS (2007) Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100, 899-904. (Pubitemid 47268287)
4. Guerciolini R (1997) Mode of action of orlistat. Int J Obes Relat Metab Disord 21, Suppl. 3, S12-S23. (Pubitemid 27271984)
5. Scheen AJ (2003) Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Drugs 63, 933-951. (Pubitemid 36570532)
6. Chiasson JL, Josse RG, Gomis R, et al. (2003) Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290, 486-494. (Pubitemid 37430502)
7. Aston LM (2006) Glycaemic index and metabolic disease risk. Proc Nutr Soc 65, 125-134. (Pubitemid 43259991)
8. Chiasson JL, Josse RG, Gomis R, et al. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359, 2072-2077. (Pubitemid 34680970)
9. Collier G & O'Dea K (1983) The effect of coingestion of fat on the glucose, insulin, and gastric inhibitory polypeptide responses to carbohydrate and protein. Am J Clin Nutr 37, 941-944. (Pubitemid 13094214)
10. Shimotoyodome A, Fukuoka D, Suzuki J, et al. (2009) Coingestion of acylglycerols differentially affects glucose-induced insulin secretion via glucose-dependent insulinotropic polypeptide in C57BL/6J mice. Endocrinology 150, 2118-2126.
11. D́az EO, Galgani JE & Aguirre CA (2006) Glycaemic index effects on fuel partitioning in humans. Obes Rev 7, 219-226.
12. Higdon JV & Frei B (2006) Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr 46, 101-123.
13. Dórea JG & da Costa TH (2005) Is coffee a functional food? Br J Nutr 93, 773-782. (Pubitemid 43899553)
14. Clifford MN (1999) Chlorogenic acids and other cinnamates-nature, occurrence and dietary burden. J Sci Food Agric 79, 362-372. (Pubitemid 29150578)
15. Murase T, Misawa K, Minegishi Y, et al. (2011) Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab 300, E122-E133.
16. Ishikawa A, Yamashita H, Hiemori M, et al. (2007) Characterization of inhibitors of postprandial hyperglycemia from the leaves of Nerium indicum. J Nutr Sci Vitaminol (Tokyo) 53, 166-173. (Pubitemid 46933027)
17. Johnston KL, Clifford MN & Morgan LM (2003) Coffee acutely modifies gastrointestinal hormone secretion and glucose tolerance in humans: glycemic effects of chlorogenic acid and caffeine. Am J Clin Nutr 78, 728-733. (Pubitemid 39663490)
18. Ida Y, Satoh Y, Ohtsuka M, et al. (1994) Phenolic constituents of Phellodendron amurense bark. Phytochemistry 35, 209-215. (Pubitemid 2032300)
19. Iwai K, Kishimoto N, Kakino Y, et al. (2004) In vitro antioxidative effects and tyrosinase inhibitory activities of seven hydroxycinnamoyl derivatives in green coffee beans. J Agric Food Chem 52, 4893-4898.
20. Kiso T, Hamayasu K, Fujita K, et al. (2003) Inhibition of betafructofuranosidases and alpha-glucosidases by synthetic thio- fructofuranoside. Biosci Biotechnol Biochem 67, 1719-1724. (Pubitemid 39251753)
21. Olthof MR, Hollman PC & Katan MB (2001) Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr 131, 66-71. (Pubitemid 32060624)
22. Olthof MR, Hollman PC, Buijsman MN, et al. (2003) Chlorogenic acid, quercetin-3-rutinoside and black tea phenols are extensively metabolized in humans. J Nutr 133, 1806-1814. (Pubitemid 36666517)
23. Baur JA, Pearson KJ, Price NL, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342. (Pubitemid 44764104)
24. Murase T, Nagasawa A, Suzuki J, et al. (2002) Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord 26, 1459-1464. (Pubitemid 36005776)
25. Greenberg JA, Boozer CN & Geliebter A (2006) Coffee, diabetes, and weight control. Am J Clin Nutr 84, 682-693. (Pubitemid 44715648)
26. Brownsey RW, Boone AN, Elliott JE, et al. (2006) Regulation of acetyl-CoA carboxylase. Biochem Soc Trans 34, 223-227.
27. Holm C (2003) Molecular mechanisms regulating hormonesensitive lipase and lipolysis. Biochem Soc Trans 31, 1120-1124. (Pubitemid 38030921)
28. Ruderman N & Prentki M (2004) AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome. Nat Rev Drug Discov 3, 340-351. (Pubitemid 38499761)
29. Bandyopadhyay GK, Yu JG, Ofrecio J, et al. (2006) Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 55, 2277-2285. (Pubitemid 44743625)
30. de Paulis T, Schmidt DE, Bruchey AK, et al. (2002) Dicinnamoylquinides in roasted coffee inhibit the human adenosine transporter. Eur J Pharmacol 442, 215-223. (Pubitemid 34626196)
31. Flatt JP (1995) Use and storage of carbohydrate and fat. Am J Clin Nutr 61, 4 Suppl., 952S-959S.
32. Cagen LM, Deng X, Wilcox HG, et al. (2005) Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem J 385, 207-216.
33. Hasty AH, Shimano H, Yahagi N, et al. (2000) Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level. J Biol Chem 275, 31069-31077.
34. Eckel RH, Fujimoto WY & Brunzell JD (1979) Gastric inhibitory polypeptide enhanced lipoprotein lipase activity in cultured preadipocytes. Diabetes 28, 1141-1142. (Pubitemid 10215022)
35. Beck B & Max JP (1983) Gastric inhibitory polypeptide enhancement of the insulin effect on fatty acid incorporation into adipose tissue in the rat. Regul Pept 7, 3-8. (Pubitemid 13019683)
36. Oben J, Morgan L, Fletcher J, et al. (1991) Effect of the entero-pancreatic hormones, gastric inhibitory polypeptide and glucagon-like polypeptide-1(7-36) amide, on fatty acid synthesis in explants of rat adipose tissue. J Endocrinol 130, 267-272.
37. Miyawaki K, Yamada Y, Ban N, et al. (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8, 738-742. (Pubitemid 34778728)